Your browser doesn't support javascript.
loading
Relation of red blood cell distribution width to risk of major adverse cardiovascular events, death, and effect of alirocumab after acute coronary syndromes.
Moriarty, Patrick M; Steg, Philippe Gabriel; McGinniss, Jennifer; Zeiher, Andreas M; White, Harvey D; Manvelian, Garen; Pordy, Robert; Loy, Megan; Jukema, J Wouter; Harrington, Robert A; Gray, Jessica V; Gorby, Lauryn K; Goodman, Shaun G; Diaz, Rafael; Bittner, Vera A; Bhatt, Deepak L; Szarek, Michael; Schwartz, Gregory G.
Affiliation
  • Moriarty PM; University of Kansas Medical Center, Kansas City, KS, USA (Dr Moriarty, Ms Gray, and Ms Gorby). Electronic address: pmoriart@kumc.edu.
  • Steg PG; Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Paris and Paris Diderot University, Sorbonne Paris Cité, FACT (French Alliance for Cardiovascular Trials), INSERM U1148, Paris, France (Dr Steg); National Heart and Lung Institute, Imperial College, Royal Brompton Hospital, London, UK (Dr Steg).
  • McGinniss J; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA (Drs McGinniss, Manvelian, and Pordy).
  • Zeiher AM; Goethe University, Frankfurt am Main, Germany (Dr Zeiher).
  • White HD; Green Lane Cardiovascular Services, Auckland City Hospital, Auckland, New Zealand (Dr White).
  • Manvelian G; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA (Drs McGinniss, Manvelian, and Pordy).
  • Pordy R; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA (Drs McGinniss, Manvelian, and Pordy).
  • Loy M; Sanofi, Bridgewater, NJ, USA (Dr Loy).
  • Jukema JW; Netherlands Heart Institute, Utrecht, the Netherlands (Dr Jukema); Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands (Dr Jukema).
  • Harrington RA; Stanford Center for Clinical Research, Department of Medicine, Stanford University, Stanford, CA (Dr Harrington).
  • Gray JV; University of Kansas Medical Center, Kansas City, KS, USA (Dr Moriarty, Ms Gray, and Ms Gorby).
  • Gorby LK; University of Kansas Medical Center, Kansas City, KS, USA (Dr Moriarty, Ms Gray, and Ms Gorby).
  • Goodman SG; Canadian VIGOUR Centre, University of Alberta, Edmonton, Alberta, Canada (Dr Goodman); St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada (Dr Goodman).
  • Diaz R; Estudios Cardiológicos Latinoamérica, Instituto Cardiovascular de Rosario, Rosario, Argentina (Dr Diaz).
  • Bittner VA; Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL, USA (Dr Bittner).
  • Bhatt DL; Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School, Boston, MA, USA (Dr Bhatt).
  • Szarek M; State University of New York, Downstate School of Public Health, Brooklyn, NY, USA (Dr Szarek); CPC Clinical Research and Division of Cardiology, University of Colorado School of Medicine, Aurora, CO, USA (Dr Szarek).
  • Schwartz GG; University of Colorado School of Medicine, Aurora, CO, USA (Dr Schwartz).
J Clin Lipidol ; 16(5): 747-756, 2022.
Article in En | MEDLINE | ID: mdl-36153281
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Acute Coronary Syndrome Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Clin Lipidol Journal subject: BIOQUIMICA / METABOLISMO Year: 2022 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Acute Coronary Syndrome Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Clin Lipidol Journal subject: BIOQUIMICA / METABOLISMO Year: 2022 Document type: Article Country of publication: